Cargando…
Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
Neuroendocrine prostate cancer (NEPC) can arise de novo, but much more commonly occurs as a consequence of a selective pressure from androgen deprivation therapy or androgen receptor antagonists used for prostate cancer (PCa) treatment. The process is known as neuroendocrine transdifferentiation. Th...
Autores principales: | Ostano, Paola, Mello-Grand, Maurizia, Sesia, Debora, Gregnanin, Ilaria, Peraldo-Neia, Caterina, Guana, Francesca, Jachetti, Elena, Farsetti, Antonella, Chiorino, Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037893/ https://www.ncbi.nlm.nih.gov/pubmed/32041153 http://dx.doi.org/10.3390/ijms21031078 |
Ejemplares similares
-
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Mello-Grand, Maurizia, et al.
Publicado: (2021) -
Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line
por: Peraldo Neia, Caterina, et al.
Publicado: (2016) -
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer
por: Lefort, Karine, et al.
Publicado: (2016) -
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021) -
Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer
por: Enriquez, Claudia, et al.
Publicado: (2021)